Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patientsAlma Tostmann, Charles M Mtabho, Hadija H Semvua, et al.
Chest|December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized TrialSanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin DosesRobin J Svensson, Rob E Aarnoutse, Andreas H Diacon, et al.
Plos One|September 17, 2010
The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosisDick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco, et al.
The Journal of Infection|January 10, 2013
Prevalence of nontuberculous mycobacteria in COPD patients with exacerbationsWouter Hoefsloot, Jakko van Ingen, Cecile Magis-Escurra, et al.
Emerging Infectious Diseases|March 12, 2011
Nontuberculous mycobacteria in respiratory tract infections, eastern AsiaSami Simons, Jakko van Ingen, Po-Ren Hsueh, et al.
The European Respiratory Journal|December 4, 2012
No human transmission of Mycobacterium malmoense in a perfect storm settingWouter Hoefsloot, Martin J Boeree, Cees van Nieuwkoop, et al.
ERJ Open Research|November 25, 2021
Treatment of severe <i>Mycobacterium avium</i> complex pulmonary disease with adjunctive amikacin and clofazimine <i>versus</i> standard regimen alone: a retrospective studySanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 20, 2009
The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scaleAnita C Schürch, Kristin Kremer, Albert Kiers, et al.
Journal of Clinical Microbiology|June 18, 2010
Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolatesJakko van Ingen, Sami Simons, Rina de Zwaan, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patientsAlma Tostmann, Charles M Mtabho, Hadija H Semvua, et al.
Chest|December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized TrialSanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin DosesRobin J Svensson, Rob E Aarnoutse, Andreas H Diacon, et al.
Plos One|September 17, 2010
The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosisDick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco, et al.
The Journal of Infection|January 10, 2013
Prevalence of nontuberculous mycobacteria in COPD patients with exacerbationsWouter Hoefsloot, Jakko van Ingen, Cecile Magis-Escurra, et al.
Emerging Infectious Diseases|March 12, 2011
Nontuberculous mycobacteria in respiratory tract infections, eastern AsiaSami Simons, Jakko van Ingen, Po-Ren Hsueh, et al.
The European Respiratory Journal|December 4, 2012
No human transmission of Mycobacterium malmoense in a perfect storm settingWouter Hoefsloot, Martin J Boeree, Cees van Nieuwkoop, et al.
ERJ Open Research|November 25, 2021
Treatment of severe <i>Mycobacterium avium</i> complex pulmonary disease with adjunctive amikacin and clofazimine <i>versus</i> standard regimen alone: a retrospective studySanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 20, 2009
The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scaleAnita C Schürch, Kristin Kremer, Albert Kiers, et al.
Journal of Clinical Microbiology|June 18, 2010
Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolatesJakko van Ingen, Sami Simons, Rina de Zwaan, et al.
Pageof 13